Arginase II inhibition prevents nitrate tolerance

British Journal of Pharmacology

Volumn 166, Issue 7, 2012, Pages 2015-2023

  Khong, S M L ^a   Andrews, K L ^a   Huynh, N N ^a   Venardos, K ^a   Aprico, A ^a   Michell, D L ^a   Zarei, M ^b   Moe, K T ^a,c   Dusting, G J ^d   Kaye, D M ^a   Chin Dusting, J P F ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c DEPARTMENT OF CARDIOLOGY   (Singapore)

^d Bernard O'Brien Inst Microsurgery   (Australia)

Author keywords

glyceryl trinitrate; nitrate tolerance; nitric oxide; reactive oxygen species

Indexed keywords

ARGINASE; ARGINASE 2; ARGININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCERYL TRINITRATE; MONOMER; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CHEMOLUMINESCENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS TOLERANCE; DRUG TOLERANCE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; MYOGRAPHY; NITRATE TOLERANCE; NONHUMAN; OXIDATIVE PHOSPHORYLATION UNCOUPLING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; UPREGULATION; VASODILATATION;

ANIMALS; AORTA, THORACIC; ARGINASE; ARGININE; BORONIC ACIDS; DRUG TOLERANCE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE III; NITROGLYCERIN; REACTIVE OXYGEN SPECIES; VASODILATOR AGENTS;

EID: 84863691052     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.01876.x     Document Type: Article

References (52)

1. Abou-Mohamed G, Kaesemeyer WH, Caldwell RB, Caldwell RW, (2000). Role of L-arginine in the vascular actions and development of tolerance to nitroglycerin. Br J Pharmacol 130: 211-218.
2. Abou-Mohamed G, Johnson JA, Jin L, El-Remessy AD, Do K, Kaesemeyer WH, et al,. (2004). Roles of superoxide, peroxynitrite, and protein kinase C in the development of tolerance to nitroglycerin. J Pharmacol Exp Ther 308: 289-299.
3. Bachetti T, Comini L, Francolini G, Bastianon D, Valetti B, Cadei M, et al,. (2004). Arginase pathway in human endothelial cells in pathophysiological conditions. J Mol Cell Cardiol 37: 515-523.
4. Berkowitz DE, White R, Li D, Minhas KM, Cernetich A, Kim S, et al,. (2003). Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 108: 2000-2006.
5. Bogle RG, Moncada S, Pearson JD, Mann GE, (1992). Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter. Br J Pharmacol 105: 768-770.
6. Caramori PR, Adelman AG, Azevedo ER, Newton GE, Parker AB, Parker JD, (1998). Therapy with nitroglycerin increases coronary vasoconstriction in response to acetylcholine. J Am Coll Cardiol 32: 1969-1974.
7. Chen Z, Zhang J, Stamler JS, (2002). Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci USA 99: 8306-8311.
8. Chicoine LG, Paffett ML, Young TL, Nelin LD, (2004). Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells. Am J Physiol Lung Cell Mol Physiol 287: L60-L68.
9. Chin-Dusting JP, Ahlers BA, Kaye DM, Kelly JJ, Whitworth JA, (2003). L-arginine transport in humans with cortisol-induced hypertension. Hypertension 41: 1336-1340.
10. Corraliza IM, Campo ML, Soler G, Modolell M, (1994). Determination of arginase activity in macrophages: a micromethod. J Immunol Methods 174: 231-235.
11. Daiber A, Oelze M, August M, Wendt M, Sydow K, Wieboldt H, et al,. (2004). Detection of superoxide and peroxynitrite in model systems and mitochondria by the luminol analogue L-012. Free Radic Res 38: 259-269.
12. Dikalov S, Fink B, Skatchkov M, Stalleicken D, Bassenge E, (1998). Formation of reactive oxygen species by pentaerithrityltetranitrate and glyceryl trinitrate in vitro and development of nitrate tolerance. J Pharmacol Exp Ther 286: 938-944.
13. Gao S, Chen J, Brodsky SV, Huang H, Adler S, Lee JH, et al,. (2004). Docking of endothelial nitric oxide synthase (eNOS) to the mitochondrial outer membrane: a pentabasic amino acid sequence in the autoinhibitory domain of eNOS targets a proteinase K-cleavable peptide on the cytoplasmic face of mitochondria. J Biol Chem 279: 15968-15974.
14. Gao X, Xu X, Belmadani S, Park Y, Tang Z, Feldman AM, et al,. (2007). TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 27: 1269-1275.
15. Gerzanich V, Ivanov A, Ivanova S, Yang JB, Zhou H, Dong Y, et al,. (2003). Alternative splicing of cGMP-dependent protein kinase I in angiotensin-hypertension: novel mechanism for nitrate tolerance in vascular smooth muscle. Circ Res 93: 805-812.
16. Gori T, Burstein JM, Ahmed S, Miner SE, Al-Hesayen A, Kelly S, et al,. (2001a). Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study. Circulation 104: 1119-1123.
17. Gori T, Mak SS, Kelly S, Parker JD, (2001b). Evidence supporting abnormalities in nitric oxide synthase function induced by nitroglycerin in humans. J Am Coll Cardiol 38: 1096-1101.
18. Huynh NN, Harris EE, Chin-Dusting JFP, Andrews KL, (2009). The vascular effects of different arginase inhibitors in rat isolated aorta and mesenteric arteries. Br J Pharmacol 156: 84-93.
19. Johnson FK, Johnson RA, Peyton KJ, Durante W, (2005). Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension. Am J Physiol Regul Integr Comp Physiol 288: R1057-R1062.
20. Kaesemeyer WH, Ogonowski AA, Jin L, Caldwell RB, Caldwell RW, (2000). Endothelial nitric oxide synthase is a site of superoxide synthesis in endothelial cells treated with glyceryl trinitrate. Br J Pharmacol 131: 1019-1023.
21. Kim JH, Bugaj LJ, Oh YJ, Bivalacqua TJ, Ryoo S, Soucy KG, et al,. (2009). Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. J Appl Physiol 107: 1249-1257.
22. Kimura M, Sudhir K, Jones M, Simpson E, Jefferis AM, Chin-Dusting JP, (2003). Impaired acetylcholine-induced release of nitric oxide in the aorta of male aromatase-knockout mice: regulation of nitric oxide production by endogenous sex hormones in males. Circ Res 93: 1267-1271.
23. Klatt P, Schmidt K, Werner ER, Mayer B, (1996). Determination of nitric oxide synthase cofactors: heme, FAD, FMN, and tetrahydrobiopterin. Methods Enzymol 268: 358-365.
24. Li H, Meininger CJ, Hawker JR, Jr, Haynes TE, Kepka-Lenhart D, Mistry SK, et al,. (2001). Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. Am J Physiol Endocrinol Metab 280: E75-E82.
25. Lim HK, Lim HK, Ryoo S, Benjo A, Shuleri K, Miriel V, et al,. (2007). Mitochondrial arginase II constrains endothelial NOS-3 activity. Am J Physiol Heart Circ Physiol 293: H3317-H3324.
26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
27. Ming X-F, Barandier C, Viswambharan H, Kwak BR, Mach F, Mazzolai L, et al,. (2004). Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction. Circulation 110: 3708-3714.
28. Morris SM, Jr, (2009). Recent advances in arginine metabolism: roles and regulation of the arginases. Br J Pharmacol 157: 922-930.
29. Münzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG, (1995). Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J Clin Invest 95: 187-194.
30. Münzel T, Hink U, Yigit H, Macharzina R, Harrison DG, Mulsch A, (1999). Role of superoxide dismutase in in vivo and in vitro nitrate tolerance. Br J Pharmacol 127: 1224-1230.
31. Münzel T, Li H, Mollnau H, Hink U, Matheis E, Hartmann M, et al,. (2000). Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability. Circ Res 86: E7-E12.
32. Münzel T, Daiber A, Mülsch A, (2005a). Explaining the phenomenon of nitrate tolerance. Circ Res 97: 618-628.
33. Münzel T, Daiber A, Ullrich V, Mulsch A, (2005b). Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol 25: 1551-1557.
34. Ozaki M, Kawashima S, Yamashita T, Hirase T, Namiki M, Inoue N, et al,. (2002). Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. J Clin Invest 110: 331-340.
35. Parnell MM, Chin-Dusting JP, Starr J, Kaye DM, (2004). In vivo and in vitro evidence for ACh-stimulated L-arginine uptake. Am J Physiol Heart Circ Physiol 287: H395-H400.
36. Ritchie RH, Quinn JM, Cao AH, Drummond GR, Kaye DM, Favaloro JM, et al,. (2007). The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivo. J Mol Cell Cardiol 42: 1119-1128.
37. Romero MJ, Platt DH, Tawfik HE, Labazi M, El-Remessy AB, Bartoli M, et al,. (2008). Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ Res 102: 95-102.
38. Ryoo S, Gupta G, Benjo A, Lim HK, Camara A, Sikka G, et al,. (2008). Endothelial arginase II: a novel target for the treatment of atherosclerosis. Circ Res 102: 923-932.
39. Sage PR, de la Lande IS, Stafford I, Bennett CL, Phillipov G, Stubberfield J, et al,. (2000). Nitroglycerin tolerance in human vessels: evidence for impaired nitroglycerin bioconversion. Circulation 102: 2810-2815.
40. Santhanam L, Lim HK, Lim HK, Miriel V, Brown T, Patel M, et al,. (2007). Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction. Circ Res 101: 692-702.
41. Schmidt K, Rehn M, Stessel H, Wolkart G, Mayer B, (2010). Evidence against tetrahydrobiopterin depletion of vascular tissue exposed to nitric oxide/superoxide or nitroglycerin. Free Radic Biol Med 48: 145-152.
42. Shi O, Morris SM, Jr, Zoghbi H, Porter CW, O'Brien WE, (2001). Generation of a mouse model for arginase II deficiency by targeted disruption of the arginase II gene. Mol Cell Biol 21: 811-813.
43. Sohn HY, Gloe T, Keller M, Schoenafinger K, Pohl U, (1999). Sensitive superoxide detection in vascular cells by the new chemiluminescence dye L-012. J Vasc Res 36: 456-464.
44. Sydow K, Daiber A, Oelze M, Chen Z, August M, Wendt M, et al,. (2004). Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. J Clin Invest 113: 482-489.
45. Szöcs K, Lassègue B, Wenzel P, Wendt M, Daiber A, Oelze M, et al,. (2007). Increased superoxide production in nitrate tolerance is associated with NAD(P)H oxidase and aldehyde dehydrogenase 2 downregulation. J Mol Cell Cardiol 42: 1111-1118.
46. Thengchaisri N, Hein TW, Wang W, Xu X, Li Z, Fossum TW, et al,. (2006). Upregulation of arginase by H2O2 impairs endothelium-dependent nitric oxide-mediated dilation of coronary arterioles. Arterioscler Thromb Vasc Biol 26: 2035-2042.
47. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, et al,. (1998). Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA 95: 9220-9225.
48. Wang EQ, Lee W-I, Fung H-L, (2002). Lack of critical involvement of endothelial nitric oxide synthase in vascular nitrate tolerance in mice. Br J Pharmacol 135: 299-302.
49. White AR, Ryoo S, Li D, Champion HC, Steppan J, Wang D, et al,. (2006). Knockdown of arginase I restores NO signaling in the vasculature of old rats. Hypertension 47: 245-251.
50. Yang Y-M, Huang A, Kaley G, Sun D, (2009). eNOS uncoupling and endothelial dysfunction in aged vessels. Am J Physiol Heart Circ Physiol 297: H1829-H1836.
51. Zhang DX, Mendoza SA, Bubolz AH, Mizuno A, Ge ZD, Li R, et al,. (2009). Transient receptor potential vanilloid type 4-deficient mice exhibit impaired endothelium-dependent relaxation induced by acetylcholine in vitro and in vivo. Hypertension 53: 532-538.
52. Zhang WZ, Venardos K, Chin-Dusting J, Kaye DM, (2006). Adverse effects of cigarette smoke on NO bioavailability: role of arginine metabolism and oxidative stress. Hypertension 48: 278-285.